CES2 and cholangiocarcinoma: Stromal evaluation showed significantly higher CES2 immunoreactivity in high grade dysplasia (BilIN grade 3) compared to non-neoplastic “normal” biliary epithelium and invasive CCA (p < 0.001 for both analyses, Fig. 2C).